Novartis Warns of Skin Problems With Epilepsy Drug

Novartis AG's epilepsy drug Trileptal has a new warning about life-threatening skin reactions reported by patients who took the medicine, the company and the Food and Drug Administration said on Tuesday. "Such serious skin reactions may be life-threatening, and some patients have required hospitalization with very rare reports of fatal outcome," Novartis said in a letter to physicians that was posted on the FDA website. The problems, reported in both adults and children, included two serious skin disorders called toxic epidermal necrolysis and Stevens-Johnson syndrome.

Reuters (http://www.reuters.com/newsArticle.jhtml?type=topNews&storyID=8231127)